Results 201 to 210 of about 82,568 (267)

Pharmacovigilance in medical cannabis therapy among physicians in Poland: pharmacovigilance knowledge, ADR reporting practice and cannabis-related safety reporting. [PDF]

Front Public Health
Kopciuch D, Kapcińska A, Kus K, Russo E.   +3 more
europepmc   +1 more source

Motor inhibition and impulsivity in alcohol use disorder and at‐risk drinking: A systematic review and meta‐analysis

Addiction, EarlyView.
Abstract Background and aims Harmful alcohol use is a global health problem, with deficits in impulse control, encompassing motor inhibition and motor impulsivity, associated with its development and persistence. We aimed to synthesise performance‐based motor inhibition and self‐reported impulsivity in individuals with alcohol use disorder (AUD) and at‐
Yuan Ding, Evan J. Livesey, Tianjian Jiao, Wenhui Huang, Warren Logge, Dominic M. D. Tran   +5 more
wiley   +1 more source

Cannabis Use Among People Aged 65 and Older: Results From an Intercept Survey in New York City. [PDF]

J Am Geriatr Soc
Han BH, Jagasia K, Simi T, Abukahok N, Palamar JJ.   +4 more
europepmc   +1 more source

Proof-of-concept trial of PP-01 for mitigating cannabis withdrawal syndrome in participants with cannabis use disorder. [PDF]

Am J Addict
Slagle AF, Constantine J, Kushner H, Graham S, Constantine G.   +4 more
europepmc   +1 more source

Sociodemographic Trends in Daily, Weekly and Less Than Weekly Cannabis Use in Australia. [PDF]

Drug Alcohol Rev
Leung J, Chan GCK, Zhang R, Hall WD, McClure-Thomas C.   +4 more
europepmc   +1 more source

"Cannabis Green Wave" versus "Nicotine Freeze": the regulatory paradox of cannabis liberalization and nicotine prohibition. [PDF]

Harm Reduct J
Farsalinos K.
europepmc   +1 more source

Trends in the Prevalence and Severity of Alcohol and Cannabis Use Disorders Among US Adults.

JAMA Psychiatry
Han B, Compton WM, Hobin JA, Volkow ND.
europepmc   +1 more source